[Cholesterol synthesis inhibitors. Clinical studies on lowering coronary risk and plaque stabilization].
Müller-Wieland
D
D
Klinik II und Poliklinik für Innere Medizin, Universität zu Köln.
Faust
M
M
Krone
W
W
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D003326:Coronary Circulation / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D015996:Survival Rate
D000924:Anticholesteremic Agents; D002784:Cholesterol